Literature DB >> 6605715

In vitro activity and beta-lactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents.

H C Neu, P Labthavikul.   

Abstract

SQ 26,917 is a monobactam antibiotic. Its in vitro activity was compared with those of aztreonam, cefotaxime, ceftazidime, and moxalactam. SQ 26,917, which contains a beta-methyl configuration on the beta-lactam ring, was similar in activity to aztreonam with the exception of greater activity against Pseudomonas aeruginosa isolates. SQ 26,917 had no activity against gram-positive isolates or anaerobic bacteria. It was not hydrolyzed by common plasmid and chromosomal beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605715      PMCID: PMC185142          DOI: 10.1128/AAC.24.2.227

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

Review 1.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

2.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

  2 in total
  8 in total

1.  In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics.

Authors:  D H Wu; A L Baltch; R P Smith
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

2.  In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 3.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

4.  Tigemonam, an oral monobactam.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  Effectiveness of aztreonam for the treatment of gonorrhea.

Authors:  A Gottlieb; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

6.  Use of discriminative models of Pseudomonas aeruginosa bacteremia in granulocytopenic rats for testing antimicrobial efficacy.

Authors:  D Johnson
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Aztreonam treatment of gram-negative septicemia.

Authors:  D Pierard; J Boelaert; H W Van Landuyt; A Naessens; L Huyghens; S Lauwers
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

Review 8.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.